Stockscreener 앱 받기
22.59
0.88%
-0.20
전일 마감가:
$22.79
열려 있는:
$22.2
하루 거래량:
1.89M
Relative Volume:
1.08
시가총액:
$3.96B
수익:
-
순이익/손실:
$-382.71M
주가수익비율:
-8.6221
EPS:
-2.62
순현금흐름:
$-325.64M
1주 성능:
-4.84%
1개월 성능:
+17.47%
6개월 성능:
+56.77%
1년 성능:
-14.88%
1일 변동 폭
$21.86
$22.85
1주일 범위
$21.86
$24.73
52주 변동 폭
$12.72
$29.49
Immunovant Inc Stock (IMVT) Company Profile
명칭
Immunovant Inc
전화
917-580-3099
주소
320 WEST 37TH STREET, NEW YORK, NY
IMVT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMVT
Immunovant Inc
|
22.59 | 3.99B | 0 | -382.71M | -325.64M | -2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Truist | Hold |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-03-03 | 개시 | Jefferies | Hold |
| 2025-01-03 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-10-09 | 재확인 | Oppenheimer | Outperform |
| 2024-03-28 | 개시 | Oppenheimer | Outperform |
| 2024-03-13 | 개시 | Goldman | Buy |
| 2024-02-20 | 개시 | JP Morgan | Overweight |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-10-13 | 업그레이드 | UBS | Neutral → Buy |
| 2023-09-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-01 | 개시 | BofA Securities | Buy |
| 2023-04-25 | 개시 | Citigroup | Buy |
| 2023-03-31 | 개시 | Piper Sandler | Overweight |
| 2023-03-30 | 개시 | Stifel | Buy |
| 2023-02-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-01-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-09-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-08 | 개시 | Wells Fargo | Equal Weight |
| 2021-08-03 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2021-08-02 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-06-01 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-06-01 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-10-12 | 개시 | Guggenheim | Buy |
| 2020-10-08 | 개시 | Stifel | Buy |
| 2020-10-02 | 개시 | Credit Suisse | Outperform |
| 2020-08-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-25 | 개시 | Raymond James | Outperform |
| 2020-07-29 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | SVB Leerink | Outperform |
모두보기
Immunovant Inc 주식(IMVT)의 최신 뉴스
Immunovant COO Gloria sells $298k in shares By Investing.com - Investing.com Nigeria
Immunovant COO Gloria sells $298k in shares - Investing.com
Immunovant Insider Sold Shares Worth $298,237, According to a Recent SEC Filing - MarketScreener
Immunovant Restructures R&D Leadership with CMO Departure - TipRanks
How analysts rate Immunovant Inc. stock todayInsider Selling & Technical Entry and Exit Tips - newser.com
Will Immunovant Inc. stock outperform value stocksTrade Exit Summary & Weekly Breakout Watchlists - newser.com
Is Immunovant Inc. stock affected by interest rate hikesJuly 2025 Gainers & Stepwise Trade Signal Implementation - newser.com
Can swing trading help recover from Immunovant Inc. losses2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
How Immunovant Inc. stock performs after earningsJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Responsive Playbooks and the IMVT Inflection - news.stocktradersdaily.com
Is Immunovant Inc. meeting your algorithmic filter criteriaPortfolio Value Summary & Safe Capital Growth Stock Tips - newser.com
Is Immunovant Inc. stock oversold or undervalued2025 Price Momentum & Weekly High Potential Alerts - newser.com
Key resistance and support levels for Immunovant Inc.Global Markets & Risk Adjusted Swing Trade Ideas - newser.com
Will Immunovant Inc. stock go up soonTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Sentiment analysis tools applied to Immunovant Inc.Weekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com
Why Immunovant Inc. stock is popular among millennials2025 Technical Overview & Community Consensus Picks - newser.com
Why Immunovant Inc. stock is recommended by analystsWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
How institutional ownership impacts Immunovant Inc. stockMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
Immunovant, Inc. (NASDAQ:IMVT) Q2 2025 Earnings Call Transcript - Insider Monkey
Immunovant Inc Stock Analysis and ForecastStock Buyback Updates & Explosive Capital Growth Plans - earlytimes.in
Immunovant’s Earnings Call Highlights Clinical Success and Financial Strength - MSN
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus - MSN
Immunovant stock rating reiterated by Oppenheimer, cites progress in autoimmune portfolio - Investing.com South Africa
Immunovant, Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript - Insider Monkey
Decoding Immunovant Inc (IMVT): A Strategic SWOT Insight - GuruFocus
Immunovant Reports Q2 2025 Financials and Clinical Progress - TipRanks
Immunovant (IMVT) Receives a Buy from H.C. Wainwright - The Globe and Mail
Immunovant Bets Big On Autoimmune Drug Pipeline Progress - Finimize
Earnings call transcript: Immunovant Q2 2025 shows innovation amid losses By Investing.com - Investing.com Nigeria
Earnings call transcript: Immunovant Q2 2025 shows innovation amid losses - Investing.com India
[10-Q] Immunovant, Inc. Quarterly Earnings Report | IMVT SEC FilingForm 10-Q - Stock Titan
IMMUNOVANT Earnings Results: $IMVT Reports Quarterly Earnings - Quiver Quantitative
[8-K] Immunovant, Inc. Reports Material Event | IMVT SEC FilingForm 8-K - Stock Titan
Immunovant Inc (IMVT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):